Literature DB >> 8586979

Impaired mitochondrial translation in human myoblasts harbouring the mitochondrial DNA tRNA lysine 8344 A-->G (MERRF) mutation: relationship to proportion of mutant mitochondrial DNA.

M G Hanna1, I P Nelson, J A Morgan-Hughes, A E Harding.   

Abstract

The mitochondrial DNA transfer RNA lysine A8344G mutation is commonly associated with the MERRF (myoclonus epilepsy with ragged red fibre) phenotype. The molecular pathogenesis of disease associated with this mutation is unclear. Theoretically, a mitochondrial tRNA mutation might affect transcription or translation, or both. We therefore studied these processes in cloned primary human myoblast cultures containing different proportions of mutant mtDNA. No abnormality of transcription was observed. However, there was a progressive decrease in mitochondrially encoded protein synthesis as the proportion of mutant mtDNA increased. Furthermore, there was evidence that subunits were differentially affected, based on selective reduction of cytochrome c oxidase subunits with relatively low proportions of mutant mtDNA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8586979     DOI: 10.1016/0022-510x(95)00022-t

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  8 in total

Review 1.  Mitochondrial threshold effects.

Authors:  Rodrigue Rossignol; Benjamin Faustin; Christophe Rocher; Monique Malgat; Jean-Pierre Mazat; Thierry Letellier
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

2.  Modulating mtDNA heteroplasmy by mitochondria-targeted restriction endonucleases in a 'differential multiple cleavage-site' model.

Authors:  S R Bacman; S L Williams; D Hernandez; C T Moraes
Journal:  Gene Ther       Date:  2007-06-28       Impact factor: 5.250

Review 3.  The relationship between pluripotency and mitochondrial DNA proliferation during early embryo development and embryonic stem cell differentiation.

Authors:  J M Facucho-Oliveira; J C St John
Journal:  Stem Cell Rev Rep       Date:  2009-04-03       Impact factor: 5.739

4.  Aminoacylation properties of pathology-related human mitochondrial tRNA(Lys) variants.

Authors:  Marie Sissler; Mark Helm; Magali Frugier; Richard Giege; Catherine Florentz
Journal:  RNA       Date:  2004-05       Impact factor: 4.942

5.  Cytochrome c oxidase deficiency associated with the first stop-codon point mutation in human mtDNA.

Authors:  M G Hanna; I P Nelson; S Rahman; R J Lane; J Land; S Heales; M J Cooper; A H Schapira; J A Morgan-Hughes; N W Wood
Journal:  Am J Hum Genet       Date:  1998-07       Impact factor: 11.025

Review 6.  Mitochondrial disease: mutations and mechanisms.

Authors:  Matthew McKenzie; Danae Liolitsa; Michael G Hanna
Journal:  Neurochem Res       Date:  2004-03       Impact factor: 3.996

Review 7.  Gene therapy of the other genome: the challenges of treating mitochondrial DNA defects.

Authors:  Gerard G M D'Souza; Sarathi V Boddapati; Volkmar Weissig
Journal:  Pharm Res       Date:  2006-12-19       Impact factor: 4.580

8.  Organ-specific shifts in mtDNA heteroplasmy following systemic delivery of a mitochondria-targeted restriction endonuclease.

Authors:  S R Bacman; S L Williams; S Garcia; C T Moraes
Journal:  Gene Ther       Date:  2010-03-11       Impact factor: 5.250

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.